Lara Meisner

Companies

• Bicara Therapeutics Inc.General counsel Sep 12, 2024 to now¹
• Viridian Therapeutics, Inc.\DEGeneral counsel Oct 4, 2021 to Jun 20, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• VTViridian Therapeutics, Inc.\DE VRDN29,971 shares³$583.4K at $19.46Jun 16, 2023
• BTBicara Therapeutics Inc. BCAX0 shares⁴Sep 29, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 29, 2025Sold 33,807 shares at $14.75 of Bicara Therapeutics Inc.⁴
• Sep 29, 2025Exercised options 33,807 shares at $9.24 of Bicara Therapeutics Inc.⁴
• Sep 15, 2025Sold 15,829 shares at $11.49 of Bicara Therapeutics Inc.⁵
• Sep 15, 2025Exercised options 15,829 shares at $5.45 of Bicara Therapeutics Inc.⁵
• Jun 16, 2025Sold 15,829 shares at $10.43 of Bicara Therapeutics Inc.⁶
• Jun 16, 2025Exercised options 15,829 shares at $5.45 of Bicara Therapeutics Inc.⁶
• Mar 14, 2025Sold 30,620 shares at $13.24 of Bicara Therapeutics Inc.⁷
• Mar 14, 2025Sold 48,526 shares at $12.69 of Bicara Therapeutics Inc.⁷
• Mar 14, 2025Exercised options 79,146 shares at $5.45 of Bicara Therapeutics Inc.⁷
• Jun 16, 2023Sold 27 shares at $28.35 of Viridian Therapeutics, Inc.\DE³
• Jun 16, 2023Exercised options 27 shares at $23.03 of Viridian Therapeutics, Inc.\DE³
• Jun 15, 2023Sold 2,269 shares at $28.02 of Viridian Therapeutics, Inc.\DE³
• Jun 15, 2023Exercised options 2,269 shares at $23.03 of Viridian Therapeutics, Inc.\DE³
• Jun 6, 2023Sold 5,126 shares at $25.02 of Viridian Therapeutics, Inc.\DE⁸
• Jun 6, 2023Exercised options 5,126 shares at $18.51 of Viridian Therapeutics, Inc.\DE⁸
• Jun 5, 2023Sold 499 shares at $25.03 of Viridian Therapeutics, Inc.\DE⁸
• Jun 5, 2023Exercised options 499 shares at $18.51 of Viridian Therapeutics, Inc.\DE⁸
• Jun 2, 2023Sold 1,875 shares at $24.21 of Viridian Therapeutics, Inc.\DE⁸
• Jun 2, 2023Exercised options 1,875 shares at $14.00 of Viridian Therapeutics, Inc.\DE⁸
• Mar 9, 2023Sold 29,971 shares at $29.07 of Viridian Therapeutics, Inc.\DE⁹
• Jan 23, 2023Sold 6,843 shares at $35.66 of Viridian Therapeutics, Inc.\DE¹⁰
• Jan 23, 2023Exercised options 1,872 shares at $14.00 of Viridian Therapeutics, Inc.\DE¹⁰
• Jan 23, 2023Exercised options 4,971 shares at $23.03 of Viridian Therapeutics, Inc.\DE¹⁰
• Dec 21, 2022Sold 16,326 shares at $29.19 of Viridian Therapeutics, Inc.\DE¹¹
• Dec 21, 2022Exercised options 16,326 shares at $23.03 of Viridian Therapeutics, Inc.\DE¹¹